Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Katharina Feister"'
Autor:
Breelyn A. Wilky, Shreyaskumar Patel, Vinod Ravi, Jonathan C. Trent, Jonathan Cohen, Pasquale Benedetto, Robert G. Maki, Alexander J. Lazar, Andrew E. Rosenberg, Cristiam Moreno Tellez, Yupanqui Caldas, Jamie Sheren, Marta Braschi-Amirfarzan, Jyothi Jagannathan, Karan Malik, Katharina Feister, Kevin Sweet, Behrang Amini, Ty K. Subhawong, Angela Pang, Heath W. Catoe, Peter J. DeMaria, Robert Hsu, Neeta Somaiah, Ravin Ratan, Junxiao Hu, Michael J. Nathenson
Supplementary Data from Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1660a371b227773d368d4c52d6dcc72a
https://doi.org/10.1158/1078-0432.22486985
https://doi.org/10.1158/1078-0432.22486985
Autor:
Breelyn A. Wilky, Shreyaskumar Patel, Vinod Ravi, Jonathan C. Trent, Jonathan Cohen, Pasquale Benedetto, Robert G. Maki, Alexander J. Lazar, Andrew E. Rosenberg, Cristiam Moreno Tellez, Yupanqui Caldas, Jamie Sheren, Marta Braschi-Amirfarzan, Jyothi Jagannathan, Karan Malik, Katharina Feister, Kevin Sweet, Behrang Amini, Ty K. Subhawong, Angela Pang, Heath W. Catoe, Peter J. DeMaria, Robert Hsu, Neeta Somaiah, Ravin Ratan, Junxiao Hu, Michael J. Nathenson
Purpose:Determine whether specific CTNNB1 or APC mutations in patients with desmoid tumor were associated with differences in clinical responses to systemic treatments.Experimental Design:We established a multi-institutional dataset of previously tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46ea4b558620bf4aabe4dceefc4277c0
https://doi.org/10.1158/1078-0432.c.6532433.v1
https://doi.org/10.1158/1078-0432.c.6532433.v1
Autor:
Breelyn A. Wilky, Shreyaskumar Patel, Vinod Ravi, Jonathan C. Trent, Jonathan Cohen, Pasquale Benedetto, Robert G. Maki, Alexander J. Lazar, Andrew E. Rosenberg, Cristiam Moreno Tellez, Yupanqui Caldas, Jamie Sheren, Marta Braschi-Amirfarzan, Jyothi Jagannathan, Karan Malik, Katharina Feister, Kevin Sweet, Behrang Amini, Ty K. Subhawong, Angela Pang, Heath W. Catoe, Peter J. DeMaria, Robert Hsu, Neeta Somaiah, Ravin Ratan, Junxiao Hu, Michael J. Nathenson
Supplementary Figure from Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2de9fef1c3ea88ce954828dbbed88edc
https://doi.org/10.1158/1078-0432.22486967
https://doi.org/10.1158/1078-0432.22486967
Autor:
Michael J. Nathenson, Junxiao Hu, Ravin Ratan, Neeta Somaiah, Robert Hsu, Peter J. DeMaria, Heath W. Catoe, Angela Pang, Ty K. Subhawong, Behrang Amini, Kevin Sweet, Katharina Feister, Karan Malik, Jyothi Jagannathan, Marta Braschi-Amirfarzan, Jamie Sheren, Yupanqui Caldas, Cristiam Moreno Tellez, Andrew E. Rosenberg, Alexander J. Lazar, Robert G. Maki, Pasquale Benedetto, Jonathan Cohen, Jonathan C. Trent, Vinod Ravi, Shreyaskumar Patel, Breelyn A. Wilky
Publikováno v:
Clinical Cancer Research. 28:4092-4104
Purpose: Determine whether specific CTNNB1 or APC mutations in patients with desmoid tumor were associated with differences in clinical responses to systemic treatments. Experimental Design: We established a multi-institutional dataset of previously
Autor:
Ty K. Subhawong, Katharina Feister, Kevin M. Sweet, Deukwoo Kwon, Breelyn A. Wilky, Noam Alperin, Jonathan C. Trent, Andrew E. Rosenberg
Publikováno v:
Radiol Imaging Cancer
PURPOSE: To determine whether MRI volumetric and image texture analysis correlates with treatment-induced biologic changes in desmoid fibromatosis (DF) earlier than conventional response criteria. MATERIALS AND METHODS: This retrospective study inclu
Publikováno v:
Clinical Cancer Research. 23:B36-B36
Ovarian cancer remains the most common cause of death due to gynecologic cancers, and due to its ambiguous symptomatology, diagnosis often occurs at late stages, and prognosis is poor. This case report describes the compassionate use of an oncolytic